Keyword: "risk calculation"

11 items were found with the keyword "risk calculation".

  • Individualized CANcer Care (I Can Care): Project 2

    PI: Jennifer J. Griggs, MD, MPH

    It's a challenge to know how much it helps to add systemic therapy (e.g., chemotherapy) to a woman's regimen of breast cancer care. For a woman with a favorable prognosis, chemotherapy may add relatively little benefit - but put her through a great deal of difficulty. Genomic testing can help understand who may benefit from chemotherapy and how it impacts the risk of recurrence. (07/01/2012 - 06/30/2017)

  • Individualized CANcer Care (I Can Care): Project 1

    PI: Reshma Jagsi, MD, DPhil

    Making individualized choices about surgery and radiation is challenging for patients and clinicians. This project is looking at ways to help make these choices with testing. Evaluative tests can help inform who might benefit from certain treatments and how much. (07/01/2012 - 06/30/2017)

  • I Can Decide

    PI: Sarah T. Hawley, PhD, MPH

    Patients newly diagnosed with breast cancer face a series of complex decisions regarding locoreginal and systemic treatment. Currently many of these decisions do not meet the definition of a high quality decision, defined as one that is both informed (based on an accurate understanding of the treatment risks and benefits) and preference-concordant (consistent with the patient's underlying preferences). I Can Decide evaluates the impact of an innovative decision tool on locoregional and systemic therapy decision making for newly diagnosed breast cancer patients. (07/01/2012 - 08/31/2017)

    Related Media:

  • Communications & Dissemination Core

    PI: Steven J. Katz, MD, MPH , Lawrence C. An, MD

    The goal of this program is to help clinicians and their patients address the challenges of individualizing the treatment of breast cancer. The Communications and Dissemination Core's primary goal is to translate key research findings into personally relevant messages for patients and clinicians. We do this by creating 1) an interactive online tool to help patients improve breast cancer treatment decision making, and 2) an interactive website to education clinicians about breast cancer practice norms, patients' experiences, and effective communication strategies. (07/01/2012 - 06/30/2017)

  • Liver Quality Decision Aid

    PI: Michael L. Volk, MD, MSc, AGAF

    Organs available for transplantation are of varying quality. Patients awaiting transplant need to balance the risk of taking a lower quality organ to keep them alive versus the risk of dying while waiting for a transplant. This decision aid includes an exercise to help people decide the level of quality they might be willing to accept, given their specific risk of death in the next 3 months. (02/01/2010 - 12/31/2014)

  • Breast Cancer Genetics Usability Test

    PI: J. Scott Roberts, PhD

    The purpose of this project is to develop and test a web-delivered, tailored decision aid for women at risk for breast and ovarian cancer. Existing educational materials are refined then offered in an interactive website featuring greater personalization of risk information, using validated risk communication techniques in a patient-friendly Web-based application.Such technologies are needed to expand the reach and improve the cost- effectiveness of breast cancer genetic services and are part of a growing movement within clinical care to provide validated patient decision aids. (03/01/2009 - 02/28/2010)

  • CECCR2 - Center of Excellence In Cancer Communications Research II

    PI: Victor J. Strecher, PhD, MPH

    The purpose of the University of Michigan Center of Excellence in Cancer Communications Research (CECCR) is to develop an efficient, theory-driven model for generating tailored health behavior interventions for many health behaviors and socio-demographic populations. (09/01/2008 - 08/31/2013)

  • Breast Cancer Genetics Network Website Improvements

    PI: J. Scott Roberts, PhD

    This study refines an existing Web-based, tailored decision aid for women at risk for breast and ovarian cancer. The existing educational materials are made more interactive, more highly tailored and personalized. (09/01/2007 - 08/31/2008)

  • SCanIT

    PI: Masahito Jimbo, MD, PhD, MPH

    Streamlining Cancer Screening Decision through Information Technology (SCanIT) aims to use information technology to link colorectal cancer (CRC) screening with health services at an integrated health system. The goal is to enhance informed decision making (IDM) for the patient and shared decision-making (SDM) between the patient and the physician. (05/01/2007 - 04/30/2008)

  • CSATS

    PI: Masahito Jimbo, MD, PhD, MPH

    Cancer Screening Adherence through Technology-Enhanced Shared Decision Making (CSATS) is a tailored behavioral intervention to improve patient adherence to colorectal cancer screening (CRC). CSATS links a computerized screening prompt/reminder system with a tailored behavioral intervention. The intervention combines a screening decision aid with a risk assessment. Upon completion of the intervention, a recommendation is provided to both patient and physician to enhance shared decision making between the two. (01/02/2006 - 08/31/2007)

  • Guide to Decide

    PI: Victor J. Strecher, PhD, MPH , Angela Fagerlin, PhD , Peter A. Ubel, MD

    Guide to Decide uses a multi-phased experimental process to explore methods of communicating risk regarding tamoxifen or raloxifene prophylaxis to women at high risk for breast cancer. (07/01/2003 - 08/31/2008)